{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T08:49:31Z","timestamp":1772527771885,"version":"3.50.1"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Diffuse peritoneal and omental infiltration of prostate cancer detected by <jats:sup>18<\/jats:sup>F-PSMA-1007 PET\/CT was rarely reported. We report a case of an 80-year-old man who was suspected of prostate carcinoma metastasis and underwent <jats:sup>18<\/jats:sup>F-PSMA-1007 PET\/CT for restaging the disease. PET\/CT imaging presented intense tracer uptake in the prostate gland, multiple lymph nodes, and bones. Interestingly, we found extremely increased radioactive uptake of diffuse peritoneum and omentum on <jats:sup>18<\/jats:sup>F-PSMA-1007 PET\/CT images, which are very rare metastatic sites for prostate cancer.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003802","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T05:10:07Z","timestamp":1625807407000},"page":"e74-e76","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Detection of Diffuse Peritoneal and Omental Metastases From Prostate Cancer With 18F-PSMA-1007 PET\/CT"],"prefix":"10.1097","volume":"47","author":[{"given":"Xiaowei","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,7,8]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.eururo.2016.06.021","article-title":"Sensitivity, specificity, and predictors of positive (68)Ga-prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis","volume":"70","year":"2016","journal-title":"Eur Urol"},{"key":"bib2-20250621","first-page":"S2588-9311(20)30090-0","article-title":"A prospective comparison of 18F-prostate-specific membrane antigen-1007 positron emission tomography computed tomography, whole-body 1.5 T magnetic resonance imaging with diffusion-weighted imaging, and single-photon emission computed tomography\/computed tomography with traditional imaging in primary distant metastasis staging of prostate cancer (PROSTAGE)","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"bib3-20250621","first-page":"32","article-title":"Prostate specific membrane antigen positron emission tomography\/computed tomography and staging high risk prostate cancer: a non-systematic review of high clinical impact literature","volume":"73","year":"2021","journal-title":"Minerva Urol Nephrol"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"e424","DOI":"10.1097\/RLU.0000000000001256","article-title":"FDG PET\/CT in peritoneal metastasis from prostate cancer","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1097\/RLU.0000000000003414","article-title":"Rapidly evolving diffuse omental carcinomatosis of prostate cancer in 68Ga-PSMA PET\/CT","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1097\/RLU.0000000000001619","article-title":"A rare case of omentum invasive prostate cancer: staging with PSMA PET\/CT imaging and response to systemic therapy","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/RLU.0000000000002843","article-title":"Detection of unusual peritoneal metastases of prostate cancer with 68Ga-prostate-specific membrane antigen PET\/CT","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.2967\/jnumed.117.204669","article-title":"Intraindividual comparison of (18)F-PSMA-1007 and (18)F-DCFPyL PET\/CT in the prospective evaluation of patients with newly diagnosed prostate carcinoma: a pilot study","volume":"59","year":"2018","journal-title":"J Nucl Med"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2967\/jnumed.119.229187","article-title":"Matched-pair comparison of (68)Ga-PSMA-11 PET\/CT and (18)F-PSMA-1007 PET\/CT: frequency of pitfalls and detection efficacy in biochemical recurrence after radical prostatectomy","volume":"61","year":"2020","journal-title":"J Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003802","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:06:49Z","timestamp":1750536409000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,8]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003802","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,8]]}}}